A study reveals that two-thirds of genetic risks for mental health conditions are shared, challenging traditional diagnostic ...

Nucleome Therapeutics ('Nucleome' or 'the Company'), a company tackling the molecular causes of inflammatory diseases through ...

By the end of March, the agency could approve multiple “national priority” voucher winners, as well as a gene therapy it ...

An analysis of the pet insurance sector, featuring data on market leaders, breed-specific risk factors, and the economics of ...

After a lengthy downturn, the biotech industry finally gathered momentum in 2025. Key readouts in obesity, infectious disease ...

A new paper published in The Gerontologist provides the most comprehensive scientific response to date addressing recent ...

At three sites where turkeys are hunted, it appeared that females were more likely to give birth to other females.

Cancer therapy and synthetic biology are converging around a shared problem that has long frustrated oncologists and ...

It may come to your attention that we are inundated with technological hype. Self-driving cars, human-like robots and AI ...

Ultragenyx Pharmaceutical (RARE) remains a Sell after its Phase 3 OI program failed to meet primary fracture reduction ...

Reality sometimes feels stranger than fiction. Throughout history, certain events have unfolded in ways that defy logic and ...

PlusAI, a leader in AI software for autonomous trucks, today announced the appointment of two new Board members, David C. Peterschmidt and Harry J. Harczak, Jr., seasoned leaders with decades of ...